LAE-102 is a monoclonal antibody that acts as an antagonist of activin receptor II-A (ACTRIIA/ACVR2). It shows potential for research in the fields of endocrine and metabolic disorders, oncology, and respiratory diseases.
Target:
ALK|||TGF-beta/Smad
* VAT and and shipping costs not included. Errors and price changes excepted
